NanoVibronix, Inc.
NASDAQ: NAOV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Doron Robert Besser
- Employees
- 31
- Headquarters
- Elmsford, United States
- IPO year
- 2015
- Market cap
- $1.5M
- Website
- https://www.nanovibronix.com
Loading NAOV…
Loading profile data…Frequently asked questions about NAOV
What does NanoVibronix, Inc. (NAOV) do?
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield,...
Where does NAOV trade?
NanoVibronix, Inc. (NAOV) trades on the NASDAQ Capital Market.
What sector is NAOV in?
NanoVibronix, Inc. (NAOV) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of NanoVibronix, Inc.?
Doron Robert Besser is the chief executive officer of NanoVibronix, Inc. (NAOV).
Where is NanoVibronix, Inc. headquartered?
NanoVibronix, Inc. is headquartered in United States.
Does NAOV pay a dividend?
NanoVibronix, Inc. (NAOV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NAOV go public?
NanoVibronix, Inc. (NAOV) completed its initial public offering in 2015.